References of "Gosset, Christiane"
     in
Bookmark and Share    
See detailRecommandations concernant le dépistage ciblé et le traitement de l’infection tuberculeuse latente
Comité scientifique de l'oeuvre Nationale Belge de défense contre la Tuberculose (ONBDT); Gosset, Christiane ULg

Report (2003)

Detailed reference viewed: 18 (0 ULg)
See detailRandom Response Model for estimating illicit drug prevalence among youth. A feasibility study.
Mauer, M.; Donneau, Anne-Françoise ULg; Pasquasy, N. et al

Report (2003)

Detailed reference viewed: 16 (3 ULg)
See detailEtude relative à la mise en œuvre de mécanismes d’aides en faveur des personnes en perte d’autonomie.
Le Consortium universitaire (ULB, ULg, UCL); Les membres francophones du Collège intermutualiste; Gosset, Christiane ULg

Report (2003)

Detailed reference viewed: 22 (2 ULg)
Full Text
Peer Reviewed
See detailProvider continuity in family medicine: does it make a difference for total health care costs?
De Maeseneer, Jan M; De Prins, Lutgarde; Gosset, Christiane ULg et al

in Annals of Family Medicine (2003), 1(3), 144-8

BACKGROUND: International comparisons of health care systems have shown a relationship at the macro level between a well-structured primary health care plan and lower total health care costs. The ... [more ▼]

BACKGROUND: International comparisons of health care systems have shown a relationship at the macro level between a well-structured primary health care plan and lower total health care costs. The objective of this study was to assess whether provider continuity with a family physician is related to lower health care costs using the individual patient as the unit of analysis. METHODS: We undertook a study of a stratified sample of patients (age, sex, region, insurance company) for which 2 cohorts were constructed based on the patients' utilization pattern of family medicine (provider continuity or not). Patient utilization patterns were observed for 2 years. The setting was the Belgian health care system. The participants were 4,134 members of the 2 largest health insurance companies in 2 regions (Aalst and Liege). The main outcome measures were the total health care costs of patients with and without provider continuity with a family physician, controlling for variables known to influence health care utilization (need factors, predisposing factors, enabling factors). RESULTS: Bivariate analyses showed that patients who were visiting the same family physician had a lower total cost for medical care. A multivariate linear regression showed that provider continuity with a family physician was one of the most important explanatory variables related to the total health care cost. CONCLUSIONS: Provider continuity with a family physician is related to lower total health care costs. This finding brings evidence to the debate on the importance of structured primary health care (with high continuity for family practice) for a cost-effective health policy. [less ▲]

Detailed reference viewed: 7 (0 ULg)
Full Text
Peer Reviewed
See detailCannabis, situation en 2001-2002
Noirfalise, Alfred ULg; Gosset, Christiane ULg; Maisse, L.

in Revue Médicale de Liège (2002), 57(11), 692-4

Even though its use becomes common, cannabis remains a narcotic, the risks of which are nowadays better known. Its therapeutic value still needs to be scientifically demonstrated.

Detailed reference viewed: 9 (3 ULg)
See detailDépistage de la problématique alcool en médecine générale
Gosset, Christiane ULg; Filée, Dominique ULg; Dor, B et al

Conference (2002)

Detailed reference viewed: 2 (0 ULg)
Peer Reviewed
See detailL'Observatoire Liégeois des Drogues
Neuforge, S; Gosset, Christiane ULg; Maisse, L et al

Conference (2002)

Detailed reference viewed: 8 (0 ULg)
Peer Reviewed
See detailL'audit en médecine générale : outils de dépistage et d'intervention
Filée, Dominique ULg; Gosset, Christiane ULg; Dor, B et al

Conference (2002)

Detailed reference viewed: 16 (3 ULg)
Peer Reviewed
See detailJustice-Assistance : des accords ou désaccords clairs ?
Maisse, L; Gosset, Christiane ULg; Noirfalise, A et al

Conference (2002)

Detailed reference viewed: 1 (0 ULg)
See detailAccompagnement ambulatoire des patients à haut risque de réhospitalisation et/ou institutionnalisation.
Counet, Laurence ULg; de Froidmont, C.; Filée, D. et al

Report (2002)

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailLong-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
Reginster, Jean-Yves ULg; Deroisy, Rita ULg; Rovati, Lucio C et al

in Lancet (2001), 357

BACKGROUND: Treatment of osteoarthritis is usually limited to short-term symptom control. We assessed the effects of the specific drug glucosamine sulphate on the long-term progression of osteoarthritis ... [more ▼]

BACKGROUND: Treatment of osteoarthritis is usually limited to short-term symptom control. We assessed the effects of the specific drug glucosamine sulphate on the long-term progression of osteoarthritis joint structure changes and symptoms. METHODS: We did a randomised, double-blind placebo controlled trial, in which 212 patients with knee osteoarthritis were randomly assigned 1500 mg sulphate oral glucosamine or placebo once daily for 3 years. Weightbearing, anteroposterior radiographs of each knee in full extension were taken at enrolment and after 1 and 3 years. Mean joint-space width of the medial compartment of the tibiofemoral joint was assessed by digital image analysis, whereas minimum joint-space width--ie, at the narrowest point--was measured by visual inspection with a magnifying lens. Symptoms were scored by the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index. FINDINGS: The 106 patients on placebo had a progressive joint-space narrowing, with a mean joint-space loss after 3 years of -0.31 mm (95% CI -0.48 to -0.13). There was no significant joint-space loss in the 106 patients on glucosamine sulphate: -0.06 mm (-0.22 to 0.09). Similar results were reported with minimum joint-space narrowing. As assessed by WOMAC scores, symptoms worsened slightly in patients on placebo compared with the improvement observed after treatment with glucosamine sulphate. There were no differences in safety or reasons for early withdrawal between the treatment and placebo groups. INTERPRETATION: The long-term combined structure-modifying and symptom-modifying effects of gluosamine sulphate suggest that it could be a disease modifying agent in osteoarthritis. [less ▲]

Detailed reference viewed: 34 (10 ULg)